Formats: Text / Subjects: United States / Languages: English / Copyright: Public domain / Recently Added: Within 1 Month - Digital Collections - National Library of Medicine Search Results

Start Over Formats Text ✖ Subjects United States ✖ Languages English ✖ Copyright Public domain ✖ Recently Added Within 1 Month ✖

1. CBO’s analysis of the long-term budgetary outlook: presentation at the University of Michigan’s 71st Annual Economic Outlook Conference

Author(s):: Dahl, Molly W., author
Publication:: [Washington, D.C.] : Congressional Budget Office, November 16, 2023
Subject(s):: Budgets -- trends
Federal Government
Forecasting
Health Care Costs -- trends
United States

2. Voluntary consensus standards recognition program for regenerative medicine therapies: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023
Subject(s):: Drug Industry
Government Regulation
Reference Standards
Regenerative Medicine -- legislation & jurisprudence
Regenerative Medicine -- standards
Voluntary Programs
United States
Center for Biologics Evaluation and Research (U.S.)

3. Development and licensure of vaccines to prevent COVID-19: guidance for industry

Publication:: [Silver Spring, MD] : Center for Biologics Evaluation and Research, October 2023
Subject(s):: COVID-19 Vaccines -- standards
Drug Development
Drug Industry
Government Regulation
Vaccine Development
United States

4. Benefit-risk assessment for new drug and biological products: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023
Subject(s):: Biological Products
Drug Approval
Drug Industry
Drugs, Investigational
Government Regulation
Pharmaceutical Preparations
Risk Assessment
United States

5. Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, October 19, 2023
Subject(s):: Equipment Safety
Government Regulation
Guideline Adherence
Monitoring, Physiologic
Remote Sensing Technology
United States

6. Compliance policy regarding blood and blood component donation suitability, donor eligibility and source plasma quarantine hold requirements: guidance for industry

Publication:: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023
Subject(s):: Blood Banking -- standards
Blood Donation -- standards
Blood Donors
Donor Selection -- standards
Government Regulation
Guideline Adherence
Plasma
United States

7. Policy for testing of alcohol (ethanol) and isopropyl alcohol for methanol: guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, October 2023
Subject(s):: 2-Propanol -- analysis
Drug Compounding -- standards
Drug Contamination -- prevention & control
Drug Industry
Ethanol -- analysis
Government Regulation
Methanol -- poisoning
United States

8. Human prescription drug and biological products: labeling for dosing based on weight or body surface area for ready-to-use containers : “dose banding” : guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, October 2023
Subject(s):: Biological Products -- administration & dosage
Drug Dosage Calculations
Drug Industry
Drug Labeling
Drug Packaging
Government Regulation
Injections -- standards
Prescription Drugs -- administration & dosage
Product Labeling
Product Packaging
United States

9. Real-time oncology review (RTOR): guidance for industry

Publication:: Silver Spring, MD : Center for Drug Evaluation and Research, November 2023
Subject(s):: Biological Products
Drug Approval
Drug Industry
Drugs, Investigational
Government Regulation
Neoplasms -- drug therapy
United States

10. Submitting clinical trial datasets and documentation for clinical outcome assessments using Item Response Theory: guidance for industry : technical specifications document

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, November 2023
Subject(s):: Clinical Trials as Topic
Drug Development
Drug Industry
Government Regulation
Outcome Assessment, Health Care
United States

11. Submitting patient-reported outcome data in cancer clinical trials: guidance for industry : technical specifications document

Publication:: [Silver Spring, MD] : Center for Drug Evaluation and Research, November 2023
Subject(s):: Clinical Trials as Topic
Drug Development
Drug Industry
Government Regulation
Neoplasms -- drug therapy
Patient Reported Outcome Measures
United States

12. Enforcement policy for clinical electronic thermometers: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, November 3, 2023
Subject(s):: Device Approval
Government Regulation
Guideline Adherence
Thermometers -- standards
United States

13. Enforcement policy for certain supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) submissions: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, November 2, 2023
Subject(s):: Compassionate Use Trials
Device Approval
Government Regulation
Guideline Adherence
United States

14. Notifying FDA of a permanent discontinuance or interruption in manufacturing of a device under Section 506J of the FD&C Act: guidance for industry and Food and Drug Administration staff

Publication:: Silver Spring, MD : Center for Devices and Radiological Health, November 17, 2023
Subject(s):: Correspondence as Topic
Device Approval
Government Regulation
Manufacturing Industry
United States
United States.

15. Assessing the credibility of computational modeling and simulation in medical device submissions: guidance for industry and Food and Drug Administration staff

Publication:: [Silver Spring, MD] : Center for Devices and Radiological Health, November 17, 2023
Subject(s):: Computer Simulation
Device Approval
Government Regulation
United States

16. Income of working-age veterans receiving disability compensation

Author(s):: Bass, Elizabeth, (Economist), author
Golding, Heidi L. W., author
Publication:: [Washington, D.C.] : Congressional Budget Office, December 2023
Subject(s):: Disabled Persons -- statistics & numerical data
Income -- statistics & numerical data
Insurance, Disability -- statistics & numerical data
Veterans -- statistics & numerical data
United States

17. Exploring the effects of Medicaid during childhood on the economy and the budget

Author(s):: Ash, Elizabeth, (Of Congressional Budget Office), author
Carrinton, William, author
Heller, Rebecca, (Of Congressional Budget Office), author
Hwang, Grace, (Of Congressional Budget Office), author
Publication:: [Washington, DC] : Congressional Budget Office, November 2023
Subject(s):: Budgets
Child
Federal Government
Income
Medicaid -- economics
Taxes
United States

18. CBO’s role and most recent long-term budget projections: presentation at a meeting of the National Conference of State Legislatures' budget working group

Author(s):: Dahl, Molly W., author
Publication:: [Washington, D.C.] : Congressional Budget Office, December 6, 2023
Subject(s):: Budgets -- trends
Federal Government
United States
United States. Congressional Budget Office.

19. Alternative payment models and the slowdown in federal health care spending: testimony before the Committee on the Budget, United States Senate

Author(s):: Cohen, Michael, (Of Congressional Budget Office), author
White, Chapin, author
Publication:: [Washington, D.C.] : Congressional Budget Office, October 18, 2023
Subject(s):: Accountable Care Organizations
Federal Government
Health Expenditures -- trends
Reimbursement Mechanisms
United States

20. Federal subsidies for health insurance: 2023 to 2033

Author(s):: Hale, Jessica, author
Vreeland, Emily, author
Publication:: [Washington, D.C.] : Congressional Budget Office, September 2023
Subject(s):: Financing, Government
Health Insurance Exchanges -- economics
Health Insurance Exchanges -- statistics & numerical data
Insurance, Health -- economics
Insurance, Health -- statistics & numerical data
Insurance, Health -- trends
Medical Assistance -- economics
Medical Assistance -- statistics & numerical data
Medical Assistance -- trends
United States

21. Federal budgetary effects of the activities of the Center for Medicare & Medicaid Innovation

Author(s):: Cohen, Michael, (Of Congressional Budget Office), author
Hall, Cornelia, author
Matthews, Rachel, (Of Health Management Associates), author
Robillard, Lara, author
Hale, Jessica, author
Zhang, Katie, author
Publication:: [Washington, D.C.] : Congressional Budget Office, September 2023
Subject(s):: Budgets -- trends
Federal Government
Models, Economic
United States
Center for Medicare & Medicaid Innovation (U.S.)

22. Individuals’ access and use of patient portals and smartphone health apps, 2022

Author(s):: Strawley, Catherine, author
Richwine, Chelsea J., author
Publication:: [Washington, DC] : Office of the National Coordinator for Health Information Technology, October 2023
Subject(s):: Mobile Applications
Patient Access to Records -- statistics & numerical data
Patient Portals
Smartphone
United States

23. Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Drug Costs
Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Fees
United States
Centers for Medicare & Medicaid Services (U.S.)

24. CARES Act: experts identified safeguards to help selected HHS agencies protect against potential political interference : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Government Regulation
Legislation, Medical
Politics
Professional Misconduct
United States
United States.
United States. Department of Health and Human Services

25. Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, September 19, 2023
Subject(s):: Government Regulation
Legislation, Medical
Medicare Part D -- economics
Medicare Part D -- organization & administration
Prescription Drugs -- economics
United States

26. COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: COVID-19
Disaster Planning -- economics
Disaster Planning -- organization & administration
Fraud -- prevention & control
Government Regulation
Health Personnel -- economics
Legislation, Medical
United States
United States. Health Resources and Services Administration

27. Medicaid program integrity: Opportunities exist for CMS to strengthen use of state auditor findings and collaboration : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Financial Audit -- legislation & jurisprudence
Financial Audit -- trends
Government Programs
Government Regulation
Legislation, Medical
Medicaid
State Health Planning and Development Agencies
United States
Centers for Medicare & Medicaid Services (U.S.)

28. Nursing homes: Limitations of using CMS data to identify private equity and other ownership : report to the Ranking Member, Committee on Ways and Means, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Data Accuracy
Government Regulation
Legislation, Medical
Nursing Homes -- economics
Nursing Homes -- legislation & jurisprudence
Nursing Homes -- organization & administration
United States
Centers for Medicare & Medicaid Services (U.S.)

29. COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: COVID-19 Vaccines -- supply & distribution
Global Health
Government Regulation
Immunization Programs
International Cooperation
Legislation, Medical
United States
United States. Agency for International Development

30. Tracking the funds. Specific fiscal year 2023 provisions for the Office of National Drug Control Policy

Publication:: [Washington, DC] : United States Government Accountability Office, September 2023
Subject(s):: Budgets
Government Programs -- economics
Government Regulation
Legislation, Medical
United States
United States. Office of National Drug Control Policy

31. Antiviral drugs: Economic incentives and strategies for pandemic preparedness : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, September 2023
Subject(s):: Antiviral Agents -- economics
Antiviral Agents -- supply & distribution
Government Regulation
Legislation, Medical
Pandemic Preparedness
Technology Assessment, Biomedical
United States

32. Medicare: Performance-based and geographic adjustments to physician payments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:: Washington, DC : United States Government Accountability Office, October 19, 2023
Subject(s):: Access to Primary Care -- statistics & numerical data
Government Regulation
Health Inequities
Health Promotion -- economics
Medicare
Primary Prevention
United States

33. Mental health services: State should collect ongoing feedback to ensure overseas employees’ needs are being met : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, October 2023
Subject(s):: Foreign Professional Personnel -- psychology
Government Employees -- psychology
Government Regulation
Legislation, Medical
Mental Health Services
Workload
United States
United States. Agency for International Development

34. Public health preparedness: Building and maintaining infrastructure beyond the COVID-19 pandemic : report to congressional committees

Publication:: Washington, DC : United States Government Accountability Office, November 2023
Subject(s):: Disaster Planning
Government Regulation
Legislation, Medical
Public Health
Public Health Infrastructure
COVID-19
United States

35. Indian Health Service: Many federal facilities are in fair or poor condition and better data are needed on medical equipment : report to congressional requesters

Publication:: Washington, DC : United States Government Accountability Office, November 2023
Subject(s):: Equipment and Supplies
Facility Regulation and Control
Government Regulation
Health Facility Administration
Health Facility Environment
Legislation, Medical
United States
United States. Indian Health Service

36. Veterans health care: VA has taken steps to improve its appointment scheduling process, but additional actions are needed : testimony before the Special Committee on Aging, U.S. Senate

Publication:: Washington, DC : United States Government Accountability Office, May 17, 2023
Subject(s):: Appointments and Schedules
Government Regulation
Legislation, Medical
Veterans Health Services -- organization & administration
United States
United States. Department of Veterans Affairs

37. FDA could take stronger enforcement action against tobacco retailers with histories of sales to youth and other violations

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):: Government Regulation
Health Policy
Tobacco Control
Tobacco Industry -- legislation & jurisprudence
United States
United States. Food and Drug Administration

38. CDC provided oversight and assistance: however, ELC recipients still faced challenges in implementing COVID-19 screening testing programs

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):: COVID-19 Testing -- instrumentation
Government Programs
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

39. Home health agencies rarely furnished services via telehealth early in the COVID-19 public health emergency

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):: COVID-19
Financial Audit
Government Regulation
Home Care Services -- legislation & jurisprudence
Telemedicine
United States

40. Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns

Publication:: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):: Ethnic and Racial Minorities -- statistics & numerical data
Government Regulation
Health Inequities
Healthcare Disparities
Medicaid
Morphinans -- supply & distribution
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

41. Medicare could save millions if it implements an expanded hospital transfer payment policy for early discharges to post acute care

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):: Financial Audit
Government Regulation
Medicare Part A -- economics
Medicare Part A -- organization & administration
Patient Transfer -- economics
Subacute Care -- economics
United States

42. The Strategic National Stockpile was not positioned to respond effectively to the COVID-19 pandemic

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):: COVID-19
Government Regulation
Pandemic Preparedness
Strategic Stockpile -- organization & administration
United States

43. National uninsured rate remained unchanged in the second quarter of 2023

Publication:: Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, November 2023
Subject(s):: Insurance Coverage -- statistics & numerical data
Insurance Coverage -- trends
Medically Uninsured -- statistics & numerical data
United States

44. States face ongoing challenges in meeting third-party liability requirements for ensuring that Medicaid functions as the payer of last resort

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):: Financial Audit
Government Regulation
Insurance, Health, Reimbursement -- legislation & jurisprudence
Medicaid -- economics
State Health Plans
United States

45. Trends in ownership structures of U.S. nursing homes and the relationship with facility traits and quality of care (2013-2022)

Author(s):: Stevenson, David G. (David George), author
Peterson, Hannah, author
Skinner, Robert, (Of Vanderbilt School of Medicine), author
Ndrianasy, Estrella, author
Braun, Robert Tyler, author
Unruh, Mark, author
Fernandez, Rahul, author
Publication:: Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy, November 13, 2023
Subject(s):: Nursing Homes -- organization & administration
Ownership -- trends
Quality of Health Care
United States

46. Community care hubs: a promising model for health and social care coordination

Author(s):: Breslau, Joshua, author
Rasmussen, Petra W., author
Qureshi, Nabeel Shariq, author
Peet, Evan D., author
Publication:: [Washington, D.C.] : Office of the Assistant Secretary for Planning and Evaluation, Administration for Community Living, U.S. Deparment of Health and Human Serivcies, November 2023
Subject(s):: Community Health Services -- organization & administration
Social Determinants of Health
Social Support
United States

47. CDC’s internal control weaknesses led to its initial COVID-19 test kit failure, but CDC ultimately created a working test kit

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):: COVID-19 Testing -- instrumentation
Equipment Failure Analysis
Government Regulation
United States
Centers for Disease Control and Prevention (U.S.)

48. Review of Medicare administrative contractor information security program evaluations for fiscal year 2022

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):: Computer Security -- standards
Government Regulation
Medicare -- organization & administration
Quality Control
United States

49. The risk of misuse and diversion of buprenorphine for opioid use disorder in Medicare Part D continues to appear low: 2022

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):: Buprenorphine
Drug Users -- statistics & numerical data
Government Regulation
Medicare Part D -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Prescription Drug Diversion -- statistics & numerical data
United States

50. CMS can do more to leverage Medicare claims data to identify unreported incidents of potential abuse or neglect

Publication:: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):: Child Abuse -- legislation & jurisprudence
Elder Abuse -- legislation & jurisprudence
Government Regulation
Medicare -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)